{"transactions":[{"id":4639776,"issuer":{"id":184313,"kind":"organization","name":"Retension Pharmaceuticals, Inc.","symbol":"RTSN"},"owners":[{"id":184315,"kind":"person","name":"Keller Eric L.","position":1,"cik":"0002156365","reported_name":"Keller Eric L.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF EXECUTIVE OFFICER"}}],"security":"Series B Convertible Preferred Stock","published_at":"2026-10-13T22:12:28.000Z","date":"2026-10-13","kind":"exercise","planned":false,"acquired":false,"shares":31368,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each share of Series B Convertible Preferred Stock (the \"Series B Preferred Stock\") converted automatically into one share of Common Stock immediately prior to the closing of the Issuer's initial public offering without payment of consideration. The Series B Preferred Stock had no expiration date."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Each share of Series B Convertible Preferred Stock (the \"Series B Preferred Stock\") converted automatically into one share of Common Stock immediately prior to the closing of the Issuer's initial public offering without payment of consideration. The Series B Preferred Stock had no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Each share of Series B Convertible Preferred Stock (the \"Series B Preferred Stock\") converted automatically into one share of Common Stock immediately prior to the closing of the Issuer's initial public offering without payment of consideration. The Series B Preferred Stock had no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Each share of Series B Convertible Preferred Stock (the \"Series B Preferred Stock\") converted automatically into one share of Common Stock immediately prior to the closing of the Issuer's initial public offering without payment of consideration. The Series B Preferred Stock had no expiration date."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":31368},"source":{"system":"sec-edgar","filing":"0001213900-26-109160","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/2156365/000121390026109160/ownership.xml","form_type":"4"}},{"id":4639775,"issuer":{"id":184313,"kind":"organization","name":"Retension Pharmaceuticals, Inc.","symbol":"RTSN"},"owners":[{"id":184315,"kind":"person","name":"Keller Eric L.","position":1,"cik":"0002156365","reported_name":"Keller Eric L.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF EXECUTIVE OFFICER"}}],"security":"Series A Convertible Preferred Stock","published_at":"2026-10-13T22:12:28.000Z","date":"2026-10-13","kind":"exercise","planned":false,"acquired":false,"shares":9662,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each share of Series A Convertible Preferred Stock (the \"Series A Preferred Stock\") converted automatically into one share of Common Stock immediately prior to the closing of the Issuer's initial public offering without payment of consideration. The Series A Preferred Stock had no expiration date."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each share of Series A Convertible Preferred Stock (the \"Series A Preferred Stock\") converted automatically into one share of Common Stock immediately prior to the closing of the Issuer's initial public offering without payment of consideration. The Series A Preferred Stock had no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Each share of Series A Convertible Preferred Stock (the \"Series A Preferred Stock\") converted automatically into one share of Common Stock immediately prior to the closing of the Issuer's initial public offering without payment of consideration. The Series A Preferred Stock had no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Each share of Series A Convertible Preferred Stock (the \"Series A Preferred Stock\") converted automatically into one share of Common Stock immediately prior to the closing of the Issuer's initial public offering without payment of consideration. The Series A Preferred Stock had no expiration date."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":9662},"source":{"system":"sec-edgar","filing":"0001213900-26-109160","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/2156365/000121390026109160/ownership.xml","form_type":"4"}},{"id":4639774,"issuer":{"id":184313,"kind":"organization","name":"Retension Pharmaceuticals, Inc.","symbol":"RTSN"},"owners":[{"id":184315,"kind":"person","name":"Keller Eric L.","position":1,"cik":"0002156365","reported_name":"Keller Eric L.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF EXECUTIVE OFFICER"}}],"security":"Stock Option (right to buy)","published_at":"2026-10-13T22:12:28.000Z","date":"2026-10-13","kind":"grant","planned":false,"acquired":true,"shares":255174,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F3","text":"Option award granted pursuant to the Issuer's 2026 Equity Incentive Plan. Twenty-five percent of the stock option vests on August 14, 2027, with the remaining stock options vesting in 36 monthly increments thereafter, subject to the Reporting Person's continued service to the Issuer on each vesting date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Option award granted pursuant to the Issuer's 2026 Equity Incentive Plan. Twenty-five percent of the stock option vests on August 14, 2027, with the remaining stock options vesting in 36 monthly increments thereafter, subject to the Reporting Person's continued service to the Issuer on each vesting date."}],"balance_after":255174,"derivative":{"exercise_price":11.63,"expiration_date":"2036-10-13","underlying":"Common Stock","underlying_shares":255174},"source":{"system":"sec-edgar","filing":"0001213900-26-109160","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/2156365/000121390026109160/ownership.xml","form_type":"4"}},{"id":4639773,"issuer":{"id":184313,"kind":"organization","name":"Retension Pharmaceuticals, Inc.","symbol":"RTSN"},"owners":[{"id":184315,"kind":"person","name":"Keller Eric L.","position":1,"cik":"0002156365","reported_name":"Keller Eric L.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF EXECUTIVE OFFICER"}}],"security":"Common Stock","published_at":"2026-10-13T22:12:28.000Z","date":"2026-10-13","kind":"exercise","planned":false,"acquired":true,"shares":31368,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Each share of Series B Convertible Preferred Stock (the \"Series B Preferred Stock\") converted automatically into one share of Common Stock immediately prior to the closing of the Issuer's initial public offering without payment of consideration. The Series B Preferred Stock had no expiration date."}],"balance_after":464407,"source":{"system":"sec-edgar","filing":"0001213900-26-109160","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/2156365/000121390026109160/ownership.xml","form_type":"4"}},{"id":4639772,"issuer":{"id":184313,"kind":"organization","name":"Retension Pharmaceuticals, Inc.","symbol":"RTSN"},"owners":[{"id":184315,"kind":"person","name":"Keller Eric L.","position":1,"cik":"0002156365","reported_name":"Keller Eric L.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF EXECUTIVE OFFICER"}}],"security":"Common Stock","published_at":"2026-10-13T22:12:28.000Z","date":"2026-10-13","kind":"exercise","planned":false,"acquired":true,"shares":9662,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each share of Series A Convertible Preferred Stock (the \"Series A Preferred Stock\") converted automatically into one share of Common Stock immediately prior to the closing of the Issuer's initial public offering without payment of consideration. The Series A Preferred Stock had no expiration date."}],"balance_after":433039,"source":{"system":"sec-edgar","filing":"0001213900-26-109160","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/2156365/000121390026109160/ownership.xml","form_type":"4"}},{"id":4639771,"issuer":{"id":184313,"kind":"organization","name":"Retension Pharmaceuticals, Inc.","symbol":"RTSN"},"owners":[{"id":184315,"kind":"person","name":"Keller Eric L.","position":1,"cik":"0002156365","reported_name":"Keller Eric L.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF EXECUTIVE OFFICER"}}],"security":"Common Stock","published_at":"2026-10-13T22:12:28.000Z","date":"2026-10-13","kind":"purchase","planned":false,"acquired":true,"shares":20800,"price":12,"value":249600.0,"ownership":{"direct":true},"balance_after":423377,"source":{"system":"sec-edgar","filing":"0001213900-26-109160","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2156365/000121390026109160/ownership.xml","form_type":"4"}}]}